Effects of co-occurring depression on treatment for anxiety disorders: Analysis of outcomes from a large primary care effectiveness trial

Journal of Clinical Psychiatry

Volumn 73, Issue 12, 2012, Pages 1509-1516

  Campbell Sills, Laura ^a   Sherbourne, Cathy D ^c   Roy Byrne, Peter ^g   Craske, Michelle G ^d   Sullivan, Greer ^h   Bystritsky, Alexander ^e   Lang, Ariel J ^f   Chavira, Denise A ^a   Rose, Raphael D ^d   Welch, Stacy Shaw ^g   Stein, Murray B ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c RAND CORPORATION   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^g UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; COGNITIVE THERAPY; COMPUTER ASSISTED THERAPY; CONTROLLED STUDY; COORDINATED ANXIETY LEARNING AND MANAGEMENT; DEPRESSION; DISABILITY; FEMALE; GENERALIZED ANXIETY DISORDER; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PANIC; POSTTRAUMATIC STRESS DISORDER; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROGNOSIS; PSYCHIATRIC TREATMENT; RANDOMIZED CONTROLLED TRIAL; REMISSION; SOCIAL PHOBIA; TREATMENT RESPONSE;

EID: 84871826406     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.12m07955     Document Type: Article

References (35)

1. Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617-627. doi:10.101/archpsyc.62.6. 617 PubMed (Pubitemid 40973437)
2. Hasin DS, Goodwin RD, Stinson FS, et al. Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry. 2005;62(10):1097-1106. doi:10.101/archpsyc.62.10.1097 PubMed (Pubitemid 41396935)
3. Brown TA, Campbell LA, Lehman CL, et al. Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample. J Abnorm Psychol. 2001;110(4):585-599. doi:10.1037/021-843X.10.4.585 PubMed (Pubitemid 33049422)
4. Roy-Byrne P, Craske MG, Sullivan G, et al. Delivery of evidence-based treatment for multiple anxiety disorders in primary care: a randomized controlled trial. JAMA. 2010;303(19):1921-1928. doi:10.101/jama.2010.608 PubMed
5. Huppert JD. Anxiety disorders and depression comorbidity. In: Antony MMS, Stein MB, eds. Oxford Handbook of Anxiety and Related Disorders. New York, NY: Oxford University Press; 2009:576-586.
6. Kraemer HC, Wilson GT, Fairburn CG, et al. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry. 2002;59(10):877-883. doi:10.101/archpsyc.59.10.87 PubMed
7. Chambless DL, Tran GQ, Glass CR. Predictors of response to cognitive-behavioral group therapy for social phobia. J Anxiety Disord. 1997;11(3):221-240. doi:10.1016/S087-6185(97)08-X PubMed (Pubitemid 27338641)
8. Abramowitz JS. Treatment of obsessive-compulsive disorder in patients who have comorbid major depression. J Clin Psychol. 2004;60(11):1133-1141. doi:10.102/jclp.2078 PubMed (Pubitemid 39392086)
9. van Balkom AJLM, van Boeijen CA, Boeke AJP, et al. Comorbid depression, but not comorbid anxiety disorders, predicts poor outcome in anxiety disorders. Depress Anxiety. 2008;25(5):408-415. doi:10.102/da.20386 PubMed (Pubitemid 351758599)
10. Keijsers GPJ, Hoogduin CAL, Schaap CPDR. Prognostic factors in the behavioral treatment of panic disorder with and without agoraphobia. Behav Ther. 1994;25(4):689-708. doi:10.1016/S05-7894(05)80204-7
11. Keijsers GPJ, Hoogduin CAL, Schaap CPDR. Predictors of treatment outcome in the behavioral treatment of obsessive-compulsive disorder. Br J Psychiatry. 1994;165(6):781-786. doi:10.192/bjp.165.6.781 PubMed (Pubitemid 24361817)
12. Chavira DA, Stein MB, Golinelli D, et al. Predictors of clinical improvement in a randomized effectiveness trial for primary care patients with panic disorder. J Nerv Ment Dis. 2009;197(10):715-721. doi:10.1097/NMD. 0b013e3181b97d4d PubMed
13. McLean PD, Woody S, Taylor S, et al. Comorbid panic disorder and major depression: implications for cognitive-behavioral therapy. J Consult Clin Psychol. 1998;66(2):240-247. doi:10.1037/02-06X.6.2.240 PubMed (Pubitemid 28208306)
14. Steketee G, Siev J, Fama JM, et al. Predictors of treatment outcome in modular cognitive therapy for obsessive-compulsive disorder. Depress Anxiety. 2011;28(4):333-341. doi:10.102/da.20785 PubMed
15. Brown TA, Antony MM, Barlow DH. Diagnostic comorbidity in panic disorder: effect on treatment outcome and course of comorbid diagnoses following treatment. J Consult Clin Psychol. 1995;63(3):408-418. doi:10.1037/02-06X.63.3. 408 PubMed
16. Aaronson CJ, Shear MK, Goetz RR, et al. Predictors and time course of response among panic disorder patients treated with cognitive-behavioral therapy. J Clin Psychiatry. 2008;69(3):418-424. doi:10.408/JCP.v69n0312 PubMed (Pubitemid 351549395)
17. Allen LB, White KS, Barlow DH, et al. Cognitive-behavior therapy (CBT) for panic disorder: relationship of anxiety and depression comorbidity with treatment outcome. J Psychopathol Behav Assess. 2010;32(2):185-192. doi:10.107/s10862-09-9151-3 PubMed
18. Erwin BA, Heimberg RG, Juster H, et al. Comorbid anxiety and mood disorders among persons with social anxiety disorder. Behav Res Ther. 2002;40(1):19-35. doi:10.1016/S05-7967(0)014-5 PubMed (Pubitemid 33064419)
19. Whisman MA. Mediators and moderators of change in cognitive therapy of depression. Psychol Bull. 1993;114(2):248-265. doi:10.1037/03-2909.14.2.248 PubMed
20. Amir N, Taylor CT, Donohue MC. Predictors of response to an attention modification program in generalized social phobia. J Consult Clin Psychol. 2011;79(4):533-541. doi:10.1037/a023808 PubMed
21. Dow MG, Kenardy JA, Johnston DW, et al. Prognostic indices with brief and standard CBT for panic disorder, 2: moderators of outcome. Psychol Med. 2007;37(10):1503-1509. PubMed (Pubitemid 47581420)
22. Craske MG, Stein MB, Sullivan G, et al. Disorder-specific impact of coordinated anxiety learning and management treatment for anxiety disorders in primary care. Arch Gen Psychiatry. 2011;68(4):378-388. doi:10.101/ archgenpsychiatry.201.25 PubMed
23. Means-Christensen AJ, Sherbourne CD, Roy-Byrne PP, et al. Using five questions to screen for five common mental disorders in primary care: diagnostic accuracy of the Anxiety and Depression Detector. Gen Hosp Psychiatry. 2006;28(2):108-118. doi:10.1016/j.genhospsych.205.08.010 PubMed (Pubitemid 43324672)
24. Sullivan G, Craske MG, Sherbourne C, et al. Design of the Coordinated Anxiety Learning and Management (CALM) study: innovations in collaborative care for anxiety disorders. Gen Hosp Psychiatry. 2007;29(5):379-387. doi:10.1016/j.genhospsych.207.04.05 PubMed (Pubitemid 47410298)
25. Craske MG, Rose RD, Lang A, et al. Computer-assisted delivery of cognitive behavioral therapy for anxiety disorders in primary-care settings. Depress Anxiety. 2009;26(3):235-242. doi:10.102/da.20542 PubMed
26. Rose RD, Lang AJ, Welch SS, et al. Training primary care staff to deliver a computer-assisted cognitive-behavioral therapy program for anxiety disorders. Gen Hosp Psychiatry. 2011;33(4):336-342. doi:10.1016/j.genhospsych.201.04.01 PubMed
27. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(suppl 20):22-33, quiz 34-57. PubMed
28. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613. doi:10.1046/j.1525-1497.201.01609606.x PubMed (Pubitemid 32823891)
29. Derogatis L. BSI-18: Brief Symptom Inventory 18 Administration, Scoring, and Procedures Manual. Minneapolis, MN: NCS Pearson, Inc; 2001.
30. Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. Int Clin Psychopharmacol. 1996;11(suppl 3):89-95. doi:10.1097/04850-1960603-015 PubMed (Pubitemid 26373761)
31. Littell RC, Milliken GA, Stroup WW, et al. SAS System for Mixed Models. Cary, NC: SAS Institute, Inc; 1996.
32. Little R, Rubin D. Statistical Analysis with Missing Data. New York, NY: John Wiley & Sons; 1987.
33. Brick JM, Kalton G. Handling missing data in survey research. Stat Methods Med Res. 1996;5(3):215-238. doi:10.17/096280296050302 PubMed (Pubitemid 126559353)
34. Stein MB, Roy-Byrne PP, Craske MG, et al. Quality of and patient satisfaction with primary health care for anxiety disorders. J Clin Psychiatry. 2011;72(7):970-976. doi:10.408/JCP.09m05626blu PubMed
35. Tsao JC, Mystkowski JL, Zucker BG, et al. Impact of cognitive-behavioral therapy for panic disorder on comorbidity: a controlled investigation. Behav Res Ther. 2005;43(7):959-970. doi:10.1016/j.brat.204.1.013 PubMed (Pubitemid 40719615)